NCT02295046View on ClinicalTrials.gov

Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy
Interventions
DRUG

Amlodipine besylate/Atorvastatin calcium

Amlodipine besylate/Atorvastatin calcium 10/80 mg

Trial Locations (1)

Unknown

3S-Pharmacological Consultation & Research GmbH, D-27243 Harpstedt

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY